13c-uracil

Small moleculeexperimentalImaging agent

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2013 (NCT01677338)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Imaging
13-carbon

Oral

No

Parenteral

No

Topical

No

Also known as

  • 13c-uracil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01677338Phase 2Jul 1, 2013Covance, Otsuka
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
CovanceFor profit1012013
OtsukaFor profit1112013
2 organizations
Page 1 / 1